Jardine Matheson Holdings Limited (LON:JAR)

Longboard Pharmaceuticals Statistics

Total Valuation

LON:JAR has a market cap or net worth of GBP 12.45 billion. The enterprise value is 41.19 billion.

Market Cap	12.45B
Enterprise Value	41.19B

Important Dates

The last earnings date was Thursday, July 31, 2025.

Earnings Date	Jul 31, 2025
Ex-Dividend Date	Mar 20, 2025

Share Statistics

Current Share Class	291.62M
Shares Outstanding	n/a
Shares Change (YoY)	+0.69%
Shares Change (QoQ)	+0.34%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	232.00M

Valuation Ratios

The trailing PE ratio is 170.54 and the forward PE ratio is 10.32.

PE Ratio	170.54
Forward PE	10.32
PS Ratio	0.48
PB Ratio	0.32
P/TBV Ratio	0.65
P/FCF Ratio	5.00
P/OCF Ratio	3.71
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.99, with an EV/FCF ratio of 16.53.

EV / Earnings	564.30
EV / Sales	1.55
EV / EBITDA	7.99
EV / EBIT	11.56
EV / FCF	16.53

Financial Position

The company has a current ratio of 1.24, with a Debt / Equity ratio of 0.35.

Current Ratio	1.24
Quick Ratio	0.81
Debt / Equity	0.35
Debt / EBITDA	3.36
Debt / FCF	5.45
Interest Coverage	4.79

Financial Efficiency

Return on equity (ROE) is 2.76% and return on invested capital (ROIC) is 2.91%.

Return on Equity (ROE)	2.76%
Return on Assets (ROA)	2.48%
Return on Invested Capital (ROIC)	2.91%
Return on Capital Employed (ROCE)	4.86%
Revenue Per Employee	129,838
Profits Per Employee	365
Employee Count	443,000
Asset Turnover	0.42
Inventory Turnover	7.98

Taxes

In the past 12 months, LON:JAR has paid 631.36 million in taxes.

Income Tax	631.36M
Effective Tax Rate	36.89%

Stock Price Statistics

Beta (5Y)	0.43
52-Week Price Change	n/a
50-Day Moving Average	59.06
200-Day Moving Average	60.83
Relative Strength Index (RSI)	52.54
Average Volume (20 Days)	432

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, LON:JAR had revenue of GBP 25.97 billion and earned 72.99 million in profits. Earnings per share was 0.25.

Revenue	25.97B
Gross Profit	7.26B
Operating Income	2.48B
Pretax Income	1.71B
Net Income	72.99M
EBITDA	3.36B
EBIT	2.48B
Earnings Per Share (EPS)	0.25

Balance Sheet

The company has 3.98 billion in cash and 13.58 billion in debt, giving a net cash position of -9.60 billion.

Cash & Cash Equivalents	3.98B
Total Debt	13.58B
Net Cash	-9.60B
Net Cash Per Share	n/a
Equity (Book Value)	39.26B
Book Value Per Share	70.96
Working Capital	2.77B

Cash Flow

In the last 12 months, operating cash flow was 3.35 billion and capital expenditures -862.74 million, giving a free cash flow of 2.49 billion.

Operating Cash Flow	3.35B
Capital Expenditures	-862.74M
Free Cash Flow	2.49B
FCF Per Share	n/a

Margins

Gross margin is 27.94%, with operating and profit margins of 9.54% and 0.28%.

Gross Margin	27.94%
Operating Margin	9.54%
Pretax Margin	6.59%
Profit Margin	0.28%
EBITDA Margin	12.94%
EBIT Margin	9.54%
FCF Margin	9.60%

Dividends & Yields

This stock pays an annual dividend of 1.73, which amounts to a dividend yield of 3.05%.

Dividend Per Share	1.73
Dividend Yield	3.05%
Dividend Growth (YoY)	-2.38%
Years of Dividend Growth	n/a
Payout Ratio	461.00%
Buyback Yield	-0.69%
Shareholder Yield	2.36%
Earnings Yield	0.59%
FCF Yield	20.02%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LON:JAR has an Altman Z-Score of 1.29 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.29
Piotroski F-Score	7